2,5-Dichlorothiophene | CAS:3172-52-9

We serve 2,5-Dichlorothiophene CAS:3172-52-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,5-Dichlorothiophene

Chemical Name:2,5-Dichlorothiophene
CAS.NO:3172-52-9
Synonyms:2,5-Dichlorothiophene
2,5-Dichlor-thiophen
2,5-diclorothiophene
thiophene,2,5-dichloro
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 158.9±20.0 °C at 760 mmHg
Melting Point -41–40°C
Molecular Formula C4H2Cl2S
Molecular Weight 153.030
Flash Point 59.4±0.0 °C
Vapour Pressure 3.3±0.3 mmHg at 25°C
Index of Refraction 1.584
 
Specification:
Appearance:Colorless to light yellow liquid
Assay(GC):≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Brinzolamide(CAS:138890-62-7).



Contact us for information like 2,5-Dichlorothiophene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,thiophene,2,5-dichloro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,5-Dichlorothiophene Use and application,thiophene,2,5-dichloro technical grade,usp/ep/jp grade.


Related News: GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.5-(2-Bromoethyl)-2,3-Dihydrobenzofuran manufacturer “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.4-Amino-3-nitropyridine supplier “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.1,6-Dibromopyrene vendor The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.